These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 32788038

  • 21. Collaborative study for the establishment of human immunoglobulin BRP replacement batches.
    Karra D, Regourd E, Costanzo A.
    Pharmeur Bio Sci Notes; 2018; 2018():37-61. PubMed ID: 29944115
    [Abstract] [Full Text] [Related]

  • 22. Collaborative study for the establishment of replacement batches of heparin low- molecular-mass for assay biological reference preparations.
    Terao E, Daas A, Rautmann G, Buchheit KH.
    Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):30-6. PubMed ID: 21144487
    [Abstract] [Full Text] [Related]

  • 23. Collaborative study for the calibration of the Ph. Eur. prekallikrein activator in albumin BRP batches 4, 5 and 6.
    Lackner F, Daas A, Terao E.
    Pharmeur Bio Sci Notes; 2015 Oct; 2015():1-10. PubMed ID: 26830155
    [Abstract] [Full Text] [Related]

  • 24. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study.
    Xing D, Wirsing von König CH, Newland P, Riffelmann M, Meade BD, Corbel M, Gaines-Das R.
    Clin Vaccine Immunol; 2009 Mar; 16(3):303-11. PubMed ID: 19109448
    [Abstract] [Full Text] [Related]

  • 25. Establishment of replacement batches for prekallikrein activator in albumin biological reference preparation.
    Lackner F, Daas A, Terao E, Behr-Gross ME.
    Pharmeuropa Bio; 2008 Dec; 2008(1):1-6. PubMed ID: 19220976
    [Abstract] [Full Text] [Related]

  • 26. Collaborative study for the establishment of the Ph. Eur. BRP batch 1 for anti-vaccinia immunoglobulin.
    Fuchs F, Poirier B, Leparc-Goffart I, Buchheit KH.
    Pharmeuropa Bio; 2005 Sep; 2005(1):13-8. PubMed ID: 16336934
    [Abstract] [Full Text] [Related]

  • 27. Collaborative study for the establishment of erythropoietin BRP batch 4.
    Burns C, Bristow AF, Daas A, Costanzo A.
    Pharmeur Bio Sci Notes; 2015 Sep; 2015():246-53. PubMed ID: 26830170
    [Abstract] [Full Text] [Related]

  • 28. Establishment of the European Pharmacopoeia Biological Reference Preparation (Ph. Eur. BRP) for hepatitis A vaccine type B (Aventis Pasteur) batch 2.
    Buchheit KH, Daas A.
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):95-108. PubMed ID: 12448033
    [Abstract] [Full Text] [Related]

  • 29. Calibration of human coagulation factor VII concentrate Ph. Eur. BRP batch 2.
    Dodt J, Costanzo A, Daas A, Hunfeld A, Buchheit KH.
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):31-8. PubMed ID: 20223188
    [Abstract] [Full Text] [Related]

  • 30. Collaborative study for the establishment of erythropoietin BRP batch 5.
    Ferguson J, Burns CJ, Regourd E, Costanzo A.
    Pharmeur Bio Sci Notes; 2019 Apr; 2019():27-33. PubMed ID: 30880683
    [Abstract] [Full Text] [Related]

  • 31. Calibration of human coagulation factor VIII concentrate Ph. Eur. BRP Batch 4 for use in potency assays.
    Raut S, Costanzo A, Daniels S, Heath A, Buchheit KH.
    Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):1-29. PubMed ID: 21144486
    [Abstract] [Full Text] [Related]

  • 32. Establishment of a biological reference preparation for hepatitis A vaccine (inactivated, non-adsorbed).
    Stalder J, Costanzo A, Daas A, Rautmann G, Buchheit KH.
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):15-29. PubMed ID: 20223187
    [Abstract] [Full Text] [Related]

  • 33. Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay.
    Kirschbaum N, Wood L, Lachenbruch P, Weinstein M, Daas A, Rautmann G, Spieser JM, Buchheit KH.
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):31-64. PubMed ID: 12448031
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Establishment of European Pharmacopoeia BRP batch 2 for inactivated poliomyelitis vaccine for in vitro D antigen assay.
    Fuchs F, Minor P, Daas A, Milne C.
    Pharmeuropa Bio; 2003 Jul; 2003(1):23-50. PubMed ID: 14563307
    [Abstract] [Full Text] [Related]

  • 37. Establishment of the human albumin for electrophoresis Ph. Eur. BRP batches 3 and 4.
    Behr-Gross ME, Daas A, Eulig-Wien A, Christians S.
    Pharmeur Bio Sci Notes; 2015 Jul; 2015():181-9. PubMed ID: 26830166
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of two serological methods for potency testing of whole cell pertussis vaccines.
    von Hunolstein C, Gomez Miguel MJ, Pezzella C, Scopetti F, Behr-Gross ME, Halder M, Hoffmann S, Levels L, van der Gun J, Hendriksen C.
    Pharmeuropa Bio; 2008 Dec; 2008(1):7-18. PubMed ID: 19220977
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Calibration of the human immunoglobulin BRPs for ACA and molecular size (batch 1) and for Fc function and molecular size (batches 1 & 2).
    Sandberg E, Costanzo A, Daas A, Buchheit KH.
    Pharmeur Bio Sci Notes; 2012 Apr; 2012():1-15. PubMed ID: 23327889
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.